Literature DB >> 7665269

The incidence of gastroesophageal reflux in recurrent croup.

E Y Waki1, D N Madgy, W M Belenky, V C Gower.   

Abstract

The incidence of gastroesophageal reflux in recurrent croup was evaluated by a retrospective analysis of patients at the Children's Hospital of Michigan from 1986 to 1991. Sixty-six patients required hospitalization for recurrent croup during this 6-year period. Of the patients evaluated, 47% with recurrent croup had an additional diagnosis established of gastroesophageal reflux. In patients with three or more hospitalizations for croup, there was a 63% association with gastroesophageal reflux. Compared to all patients with recurrent croup, the patients with gastroesophageal reflux tended to be younger and had a shorter interval between episodes of croup. A prospective series of six cases of recurrent croup was seen in consultation. The diagnostic procedures involving lipid-laden macrophage quantitation, endoscopy, and gastroesophageal reflux scintiscans were utilized to establish the diagnosis of gastroesophageal reflux with tracheal aspiration. The results of these studies and the follow-up is discussed.

Entities:  

Mesh:

Year:  1995        PMID: 7665269     DOI: 10.1016/0165-5876(95)01168-b

Source DB:  PubMed          Journal:  Int J Pediatr Otorhinolaryngol        ISSN: 0165-5876            Impact factor:   1.675


  3 in total

Review 1.  Pediatric otolaryngologic manifestations of gastroesophageal reflux disease.

Authors:  Mark A Gilger
Journal:  Curr Gastroenterol Rep       Date:  2003-06

2.  Reliability, Safety and Effectiveness of the Bravo(TM) Capsule: A Catheter-free pH Monitoring System for Evaluation of Gastroesophageal Reflux Disease in Children.

Authors:  Manoochehr Karjoo; Mirza Beg; Shannon Kesselring
Journal:  Middle East J Dig Dis       Date:  2012-01

3.  Defining atypical croup: A case report and review of the literature.

Authors:  Raphael Hanna; Francisco Lee; Derek Drummond; Warren K Yunker
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2019-09-17       Impact factor: 1.675

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.